🚀 VC round data is live in beta, check it out!
SD Biosensor Valuation Multiples
Discover revenue and EBITDA valuation multiples for SD Biosensor and similar public comparables like Nanosonics, Synektik, CeriBell, Alpha Tau Medical and more.
SD Biosensor Overview
About SD Biosensor
SD Biosensor Inc is an in vitro diagnostic company. It aims to contribute to the improvement of quality of life through rapid and accurate disease diagnosis. It is researching and developing quick diagnostics, immunodiagnostics, molecular diagnostics, blood glucose monitoring systems for self -testing.
Founded
1999
HQ
Employees
N/A
Website
Financials (FY)
EV
$682M
SD Biosensor Financials
SD Biosensor reported last fiscal year revenue of $485M and negative EBITDA of ($461M).
In the same fiscal year, SD Biosensor generated $222M in gross profit, ($461M) in EBITDA losses, and had net loss of ($349M).
SD Biosensor P&L
In the most recent fiscal year, SD Biosensor reported revenue of $485M and EBITDA of ($461M).
SD Biosensor expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $485M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $222M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 46% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($461M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (95%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (11%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($349M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (72%) | XXX | XXX | XXX |
| Net Debt | — | — | $195M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
SD Biosensor Stock Performance
SD Biosensor has current market cap of $754M, and enterprise value of $682M.
Market Cap Evolution
SD Biosensor's stock price is $6.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $682M | $754M | 0.0% | XXX | XXX | XXX | $-2.92 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSD Biosensor Valuation Multiples
SD Biosensor trades at 1.4x EV/Revenue multiple, and (1.5x) EV/EBITDA.
SD Biosensor Financial Valuation Multiples
As of April 19, 2026, SD Biosensor has market cap of $754M and EV of $682M.
Equity research analysts estimate SD Biosensor's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SD Biosensor has a P/E ratio of (2.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $754M | XXX | $754M | XXX | XXX | XXX |
| EV (current) | $682M | XXX | $682M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (1.5x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (12.4x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.1x | XXX | XXX | XXX |
| P/E | — | XXX | (2.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 3.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SD Biosensor Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
SD Biosensor Margins & Growth Rates
SD Biosensor's revenue in the last fiscal year grew by 2%.
SD Biosensor Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (95%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 7493% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 11% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 57% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
SD Biosensor Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| SD Biosensor | XXX | XXX | XXX | XXX | XXX | XXX |
| Nanosonics | XXX | XXX | XXX | XXX | XXX | XXX |
| Synektik | XXX | XXX | XXX | XXX | XXX | XXX |
| CeriBell | XXX | XXX | XXX | XXX | XXX | XXX |
| Alpha Tau Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioventus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SD Biosensor M&A Activity
SD Biosensor acquired XXX companies to date.
Last acquisition by SD Biosensor was on XXXXXXXX, XXXXX. SD Biosensor acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by SD Biosensor
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSD Biosensor Investment Activity
SD Biosensor invested in XXX companies to date.
SD Biosensor made its latest investment on XXXXXXXX, XXXXX. SD Biosensor invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by SD Biosensor
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SD Biosensor
| When was SD Biosensor founded? | SD Biosensor was founded in 1999. |
| Where is SD Biosensor headquartered? | SD Biosensor is headquartered in South Korea. |
| Who is the CEO of SD Biosensor? | SD Biosensor's CEO is Hyo-Geun Lee. |
| Is SD Biosensor publicly listed? | Yes, SD Biosensor is a public company listed on Korea Exchange. |
| What is the stock symbol of SD Biosensor? | SD Biosensor trades under 137310 ticker. |
| When did SD Biosensor go public? | SD Biosensor went public in 2021. |
| Who are competitors of SD Biosensor? | SD Biosensor main competitors are Nanosonics, Synektik, CeriBell, Alpha Tau Medical. |
| What is the current market cap of SD Biosensor? | SD Biosensor's current market cap is $754M. |
| What is the current revenue of SD Biosensor? | SD Biosensor's last fiscal year revenue is $485M. |
| What is the current EV/Revenue multiple of SD Biosensor? | Current revenue multiple of SD Biosensor is 1.4x. |
| Is SD Biosensor profitable? | No, SD Biosensor is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.